Optical Imaging for Gum Disease
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that Optical Coherence Tomography (OCT) can effectively image and monitor gum disease by providing detailed images of the tissues in the mouth. It has been used to track improvements in gum health after treatment, making it a useful tool for diagnosing and following up on periodontal disease.
12345Optical imaging techniques like Optical Coherence Tomography (OCT) are generally considered safe for humans as they are non-invasive and do not use harmful radiation, making them suitable for imaging oral tissues.
35678Optical imaging for gum disease uses optical coherence tomography (OCT), a noninvasive method that provides detailed images of oral tissues without the need for X-rays or biopsies. This treatment is unique because it allows for real-time monitoring and early detection of periodontal disease by capturing high-resolution images of both hard and soft tissues in the mouth.
235910Eligibility Criteria
This trial is for people aged 18-75 with healthy eyes. It's designed to test a new imaging technique on various tissues, including gums, skin, and corneas.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Optical imaging of the cornea, skin, and gingiva in healthy subjects and cornea in keratoconus subjects
Follow-up
Participants are monitored for safety and effectiveness after imaging procedures